Diagnostic value of MPO in patients admitted for suspected acute coronary syndrome--a study of adult in Mostar, Bosnia and Herzegovina.

We assessed the diagnostic efficacy of plasma Myeloperoxidasis (MPO) alone or in combination with cardiac troponin I (cTnI) for detecting ACS in patients presenting with chest pain initiating within 24 h before the hospital admission. In this prospective cohort study were included all respondents who have visited outpatient clinic of internal diseases, University Hospital Mostar because of chest pain and suspected acute coronary syndrome within 24 h of the onset of the period of 6 months and the total sample consisted of 114 patients. Troponin and myeloperoxidase were significantly positively correlated at the beginning of treatment, myeloperoxidase was significantly positively associated with adverse cardiovascular events during hospitalization and myocardial infarction (p < 0.05), with the regression analysis did not show a significant predictor in the development of myocardial infarction (p > 0.05). Sensitivity of myeloperoxidase as a valid test detection of myocardial infarction at baseline was 0.15 and specificity was 0.85, suggesting good diagnostic value usable in the clinical practice.
AuthorsMirjana Vasilj, Boris Starcević, Mile Volarić, Boris Jelavić, Miro Leventić, Danijela Cuk, Slavica Corić
JournalCollegium antropologicum (Coll Antropol) Vol. 38 Issue 1 Pg. 213-7 (Mar 2014) ISSN: 0350-6134 [Print] Croatia
PMID24851620 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Troponin I
  • Peroxidase
  • Acute Coronary Syndrome (blood, diagnosis, epidemiology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers (blood)
  • Bosnia and Herzegovina
  • Chest Pain (blood, diagnosis, epidemiology)
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (blood, diagnosis, epidemiology)
  • Peroxidase (blood)
  • Risk Factors
  • Troponin I (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: